Literature DB >> 11094012

The prolonged duration of rocuronium in Chinese patients.

L M Collins1, J C Bevan, D R Bevan, G C Villar, R Kahwaji, M F Smith, F Donati.   

Abstract

We compared the potency and duration of action of rocuronium in Chinese and Caucasian patients during general anesthesia. Thirty-six women (18 Caucasian and 18 Chinese) and 36 children (18 Caucasian and 18 Chinese) were evaluated during the administration of propofol/fentanyl anesthesia. Patients in each age group were randomized into three subgroups to receive single doses of 0.06, 0. 12, or 0.18 mg/kg rocuronium (adults) or 0.12, 0.18, or 0.24 mg/kg rocuronium (children). Neuromuscular blockade was assessed by electromyography of the adductor pollicis after train-of-four (TOF) stimulation of the ulnar nerve. Dose response curves were constructed when maximum neuromuscular depression of the first twitch of the train (T(1)) was obtained. A second bolus dose of rocuronium was then administered to a total dose of 0.6 mg/kg. The times of spontaneous recovery to T(1) 10%, 25%, and 90% of control and to TOF 0.25, 0.50, and 0.70 were recorded. For both adults and children, recovery occurred later in Chinese than in Caucasian patients (P<0.05 for T(1) of 10%, 25%, 75%, and 90% and TOF to 0.7). The 50% effective dose was smaller in Chinese adults (125+/-63 vs. 159+/-66 microg/kg) and Chinese children (171+/-43 vs. 191+/-46 microg/kg) than in Caucasian adults and children, but the difference was not statistically significant. In adults, time to 25% T(1) recovery was 43+/-13 min in Chinese patients and 33+/-10 min in Caucasian patients (P<0.05). The corresponding values were more rapid for children: 30+/-10 and 24+/-6 min (P<0.05). We conclude that the recovery from rocuronium neuromuscular blockade was longer in Chinese compared with Caucasian patients and in adults compared with children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094012     DOI: 10.1097/00000539-200012000-00042

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  A randomized trial to identify optimal precurarizing dose of rocuronium to avoid precurarization-induced neuromuscular block.

Authors:  Naoko Fukano; Takahiro Suzuki; Kiyoko Ishikawa; Hitoshi Mizutani; Shigeru Saeki; Setsuro Ogawa
Journal:  J Anesth       Date:  2011-01-12       Impact factor: 2.078

2.  Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.

Authors:  Xinmin Wu; Helle Oerding; Jin Liu; Bernard Vanacker; Shanglong Yao; Vegard Dahl; Lize Xiong; Casper Claudius; Yun Yue; Yuguang Huang; Esther Abels; Henk Rietbergen; Tiffany Woo
Journal:  BMC Anesthesiol       Date:  2014-07-12       Impact factor: 2.217

3.  Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.

Authors:  Tiffany Woo; Kyo Sang Kim; Yon Hee Shim; Mi Kyeong Kim; Suk Min Yoon; Young Jin Lim; Hong Seuk Yang; Phillip Phiri; Jin Young Chon
Journal:  Korean J Anesthesiol       Date:  2013-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.